#Stem Laboratory Equipment Manufacturers India | Explore Tumblr Posts and Blogs

infotechs · 1 month

Text

Choke Valve Supplier in India Bliss Flow

Choke valves are essential components in various industrial processes, particularly in the oil and gas sector. They play a crucial role in controlling the flow rate and pressure of fluids, ensuring the safe and efficient operation of pipelines and systems. If you're looking for a reliable choke valve supplier in India, Bliss Flow is your go-to partner. In this blog, we'll delve into the importance of choke valves, their applications, and why Bliss Flow stands out as a trusted supplier in the industry.

What is a Choke Valve? A choke valve, also known as a choke, is a type of control valve used to regulate the flow of fluid through a pipeline. It is specifically designed to handle high-pressure drops, making it ideal for applications where precise flow control is necessary. Choke valves are commonly used in oil and gas production, chemical processing, and other industrial applications that require the management of high-pressure and high-temperature fluids.

Types of Choke Valves Choke valves come in various designs, each suited to specific applications:

Adjustable Choke Valve: This type allows for manual or automatic adjustment of the flow rate. It is ideal for applications requiring varying flow rates and is commonly used in wellheads and production manifolds.

Positive Choke Valve: Unlike adjustable choke valves, positive choke valves have a fixed orifice size, providing a consistent flow rate. They are used in applications where a steady flow rate is necessary.

Needle Choke Valve: Designed with a needle-like stem, this type allows for precise flow control, especially in low-flow applications. It is commonly used in laboratory settings and small-scale industrial processes.

Applications of Choke Valves Choke valves are crucial in various industrial sectors, including:

Oil and Gas Production: Choke valves are extensively used in wellhead assemblies to control the flow rate of oil and gas from the well. They help manage the pressure and flow rate to optimize production and prevent damage to downstream equipment.

Chemical Processing: In the chemical industry, choke valves regulate the flow of aggressive chemicals, ensuring safe and efficient processing.

Power Generation: Choke valves are also used in power plants to control the flow of steam and water, maintaining optimal operating conditions.

Why Choose Bliss Flow as Your Choke Valve Supplier in India? Bliss Flow is a leading supplier of high-quality choke valves in India, catering to a wide range of industrial needs. Here’s why you should choose Bliss Flow for your choke valve requirements:

Extensive Product Range: We offer a comprehensive range of choke valves, including adjustable, positive, and needle choke valves, designed to meet the diverse needs of our clients.

High-Quality Standards: At Bliss Flow, we prioritize quality and reliability. Our choke valves are manufactured using premium materials and undergo rigorous quality checks to ensure they meet international standards.

Customized Solutions: We understand that each industry has unique requirements. That’s why we offer customized solutions tailored to your specific needs, ensuring optimal performance and efficiency.

Expert Technical Support: Our team of experts is always available to provide technical support and guidance, helping you select the right choke valve for your application.

Competitive Pricing: We offer high-quality choke valves at competitive prices, ensuring you get the best value for your investment.

Conclusion Choke valves are vital for maintaining safe and efficient operations in various industries. When it comes to finding a reliable choke valve supplier in India, Bliss Flow is a name you can trust. With our extensive product range, commitment to quality, and customer-focused approach, we are well-equipped to meet all your choke valve needs. Contact us today to learn more about our products and services!

More Info : https://blissflowsystems.com/ Contact us :+91 9500953600

#ChokeValve #ChokeValveSupplierinIndia #ChokeValvedistributorinIndia

0 notes

healthcaremarketanalysis · 2 months

Text

Global Biobanking Market Worth $5.0 billion by 2028

The global biobanking market, valued at $2.9 billion in 2023, is projected to reach $5.0 billion by 2028, growing at a CAGR of 11.4%. The market's growth is driven by increasing investments and funding for biobanks, a focus on genetic testing and precision medicine, the preservation of cord blood stem cells, and favorable funding for regenerative medicine research. Challenges include the high cost of automated equipment and biospecimen sample management issues. Emerging markets such as China, India, and South Korea offer significant growth opportunities due to lower manufacturing costs and skilled resources. Key players in the market include Thermo Fisher Scientific, PHC Holdings Corporation, Becton, Dickinson and Company, QIAGEN, and Merck KGaA. The equipment segment held the largest market share in 2022, with the Asia Pacific region expected to register the highest CAGR during the forecast period.

Download PDF Brochure:

Biobanking Market Dynamics

DRIVER: Growing investments and funding for biobanks

Biobanks have gained significant recognition from governments, research organizations, and funding agencies worldwide, resulting in a rise in investments in biobanks. For example, the Biorepository and Precision Medicine Initiative (PMI) Cohort Program, funded by the US National Institutes of Health (NIH), aims to collect biological samples from one million or more individuals to create a national research resource. Similarly, the European Commission has invested in the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European infrastructure for biobanking and biomolecular resources.

RESTRAINT: High cost of automated equipment

The high cost of automated equipment is expected to restrain the growth of the market. Automated equipment, such as advanced sample handling systems, can significantly improve the efficiency and quality of biobanking operations. However, the high cost of this equipment can be a significant barrier to the entry of smaller biobanking companies or those with limited financial resources. For instance, the cost of an automated storage system can vary depending on the size and complexity of the system. The initial investment in an automated storage system can be significant, with costs ranging from tens of thousands to hundreds of thousands of dollars. In addition to the initial investment, there are ongoing maintenance and operational costs that must be considered, such as software updates, repairs, and training.

OPPORTUNITY: Emerging countries to provide lucrative opportunities

Developing countries are expected to offer significant growth opportunities for players operating in the global market due to the low-cost manufacturing advantage offered by these countries, coupled with the availability of skilled resources at lower costs. Moreover, as compared to developed markets, such as the US, Germany, and Japan, the demand for medical products in emerging Asian markets, such as China and India, is growing at a robust rate. This has prompted medical product companies to focus on these countries for future growth.

CHALLENGE: High operational cost of biobanks

Due to the increasing utilization of biospecimens for research and the emergence of new technologies, there is a growing focus on the availability and quality of biospecimens and their effective collection. However, the long-term economic situation of biobanks is still mostly unclear, which raises questions regarding their overall sustainability. Several costs add up in the complete functioning of a biobank, including in-case collection, tissue processing, storage management, sample distribution, and infrastructure and administration costs. Additionally, high investments are required to set up the required infrastructure in biobanks. For instance, the cost of installing laboratory facility infrastructure, liquid nitrogen supplies, mechanical freezers, and software systems add to the overall operating costs. Since biobanks have to store samples over a period of time, there is a significant need to optimize operations and costs for their long-term sustainability

Request 10% Customization

The equipment segment dominated biobanking market by product & service:

The equipment segment held the largest share of the global market in 2022. This is primarily attributed to the increasing number of biobanks and biosamples, due to which the demand for equipment remains high. The biobanking equipment segment encompasses a range of specialized products essential for the processing, analysis, storage, and transport of biological samples. These specimens may include human tissues, cells, blood, DNA, and other biospecimens collected from patients, donors, or research participants. The segment covers a broad spectrum of solutions and technologies catering to the diverse needs of biobanks, research institutes, and medical facilities.

The North America region catered the largest share of the biobanking market in 2022.

The biobanking market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory. This can be attributed to the increasing number of biobanks and the growing investments in biobanking infrastructure. Major healthcare institutes and research organizations in North America have made substantial commitments to expanding their biobanking capabilities. Additionally, the rising prevalence of chronic diseases and the subsequent demand for personalized medicine has fueled the growth of the biobanking market in North America, with biobanks playing a pivotal role in storing and providing high-quality biological specimens for research and development purposes.

Key players in the biobanking market include Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US).

Recent Developments

In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.

In September 2022, Cryoport entered into a strategic partnership with BioLife Plasma Services to offer supply chain solutions and service offerings, such as bioservices and cryo-processing, for BioLife Plasma Services.

Biobanking market - Report Highlights:

The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall biobanking industry.

The new edition includes the impact of the recession on the biobanking market (especially the region-wise impact in the geographic analysis section) in 2022. There is a variation in the growth rate of the market due to the ongoing recession.

Additional points such as ranges/scenarios, trends/disruptions impacting customers' businesses, pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, patent analysis, key conferences and events (2022-2023), list of key regulatory bodies, regulatory landscape, Porter's Five Forces analysis, key stakeholders, the influence of stakeholders on buying decisions, and buying criteria among end users have been added in the market overview chapter.

The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This will help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.

Recent developments help us to understand market trends and the growth strategies adopted by players in the market.

Tracking the portfolios of prominent market players helps analyze the major products in the biobanking market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.

Key market strategies/right to win, market share analysis for 2022, revenue share analysis of key market players from 2020 to 2022, and competitive leadership mapping have been added in the competitive landscape section of the report.

The new version of the report includes competitive leadership mapping for companies operating in the market. This new section is an output of a comprehensive study of the key vendors offering biobanking products. The top 25 vendors were shortlisted from a list of 50+ vendors, and these were evaluated based on market share/ranking and product footprint, rated and positioned on a 2x2 quadrant, referred to as Company Evaluation Quadrant, categorizing them as Stars, Emerging Leaders, Pervasive Players, and Participants.

The new version of the report includes the startup/SME evaluation quadrant for 10 companies operating in the biobanking market. This updated section is an output of a comprehensive study of the key startup vendors offering biobanking products. The top 10 vendors were shortlisted from a list of 50+ vendors, and these vendors were evaluated based on their product portfolio and business strategy, rated and positioned on a 2x2 quadrant, referred to as Competitive Leadership Quadrant, categorizing them as Progressive Companies, Starting Blocks, Responsive Companies, and Dynamic Companies.

In the new edition of the report, the Rest of the World is segmented into Latin America and the Middle East and Africa. Country-level markets for Brazil and the Rest of Latin America in the Latin American region have been added.

The new version of the report includes the ownership segment, which is further segmented into national/regional agencies, non-profit organizations, universities, and private organizations.

The new version of the report includes an end-user segment, which is further segmented into pharmaceutical & biotechnology companies and CROs, academic and research institutes, and hospitals.

#Biobanking Market #Biobanking Market Size #Biobanking Market Forecast #Biobanking Market Outlook

0 notes

engineeringlabsinstrument · 9 months

Text

Exploring Cutting-Edge Engineering Lab Equipment: Unveiling India's Forefront Innovations from Top Manufacturers

Leading supplier of excellent educational supplies and equipment, Engineering Labs Equipment has made an excellent reputation for itself. They are a reliable partner for educational institutions all around the nation because of their dedication to quality and innovation. Let's examine a few of their most recent innovations:

Cutting Edge Laboratory Equipment:

Advanced laboratory equipment for schools and colleges is the specialty of chemistry-lab. Their line of products, which covers everything from biology to chemistry and physics, is made to improve students' hands-on learning opportunities.

STEM Kits for Interactive Education:

Mechanical Engineering Lab Equipment Manufacturers provides a selection of STEM kits in an era where STEM (science, technology, engineering, and mathematics) education is becoming more and more popular. These kits have been carefully chosen to promote experiential learning and a thorough comprehension of basic ideas.

Engaging Whiteboards and Intelligent Classroom Solutions:

Engineering Labs Equipment provides cutting-edge interactive whiteboards and smart class solutions that turn conventional classrooms into interactive learning environments. These resources immerse students in a dynamic learning environment, enhancing the interactivity and fun of learning.

Creative Teaching Resources:

The business is aware of how important interactive instructional resources are. They use a variety of visual aids, including as charts and 3D models, to help pupils understand difficult subjects. These tools not only improve comprehension but also add enjoyment to the learning process.

Software and Platforms for E-Learning:

TVET equipment manufacturers offer software and e-learning platforms to enhance conventional teaching techniques in keeping with the digital era. With the use of these resources, teachers may design interactive classes and tests that accommodate a variety of learning preferences.

Personalization and Guidance Services:

Engineering Labs Equipment provides customisation services in recognition of the distinct requirements of every education. They work with universities and institutions to comprehend their unique needs and then provide specialised solutions that support their learning objectives.

The significance of cutting-edge instructional resources and school supplies in the ever-changing world of education cannot be emphasised. In this field, Engineering Labs Equipment is a shining example of quality, constantly providing innovative solutions that help improve education in India.

Teachers and educational institutions would be well to investigate Engineering Labs Equipment's offers if they want to stay on top of the game in education. They are a dependable partner in determining the direction of Indian education because of their dedication to quality, innovation, and personalization. Explore an array of opportunities to enhance the educational process by visiting their website.

#laboratory

0 notes

sagarg889 · 1 year

Text

Polymer Seals Market Growth, Challenges & Opportunities for Future Development 2022 to 2032

The global polymer seals market is anticipated to be worth US$ 11.3 billion by 2022. According to Future Market Insights (FMI), the market will develop at a 5.1% CAGR from 2022 to 2032. Polymer seals are utilised in many sectors, including as oil & gas, aviation, aerospace, and cars.

Polymer seals outperform traditional sealants in high temperature and corrosion resistance, both of which are key needs in all of these sectors. Between 2022 and 2032, these features are predicted to stimulate demand for polymer seals. All sectors that employ polymer seals, according to FMI, will likely accelerate in the next years, driving the polymer seals industry ahead.

Increasing defense budgets of governments are also expected in the coming years, which should generate further demand for polymer seals. For instance, the governments of India and China have been observed to increase their spending on defense in recent years, particularly for upgrading their respective air forces by investing in latest military-grade air crafts and fighter jets. Owing to the tense geopolitical climate in the region, the spending is set to rise in the near future and result in accelerating polymer seal sales.

Get a PDF Sample Copy of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16482

FMI also predicts the emergence of certain market restraints from 2022 to 2032. These restraints are likely to stem from the fact that sealant production causes significant pollution. Small scale consumers are also poised to choose polymer seal substitutes due to the high expenses associated with polymer seals.

Key Takeaways from the Polymer Seals Market Study

By material type, the polyurethane (PU) segment is anticipated to witness considerable demand growth at 9% CAGR from 2022 to 2032.

By product type, the sales of hydraulic and pneumatic seals are projected to expand at a CAGR of 6%.

By region, Europe is anticipated to witness substantial growth in the polymer seals market due to lucrative markets in Germany, Italy, and the United Kingdom.

India and China markets are anticipated to emerge as prominent polymer seals markets in Asia and register 9% and 6.0% CAGR, respectively.

By end use, transportation equipment was estimated to hold a prominent volume share of 4% in 2022.

Who is Winning?

Key players in the Polymer Seals include Freund Corp, Rotronic AG, Neu-tec Group Inc, Meter Group, Freund Corp., Novasina AG, Biobase Group, Labtron Equipment Ltd, Steroglass Srl, CapPlus Technologies, EDUTEK INSTRUMENTATION, MRC-Laboratory Equipment, and Awtester & Wisdom Instrument.

To gain a competitive advantage in the industry, key manufacturers are developing innovative polymer seal products. Market players are also heavily investing in expansion, mergers, acquisitions, and strategic partnerships to expand their global footprints.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global polymer seals market, presenting historical demand data (2017 to 2021) and forecast statistics for the period from 2022 to 2032. The study divulges compelling insights on the polymer seals market based on material type (polyurethane (PU), acrylonitrile-butadiene-rubber (NBR), fluoro-rubber (FKM), polytetrafluoroethylene (PTFE)), product type (hydraulic and pneumatic seals, rotary seals, spring energised seals), end use (transportation equipment, industrial machinery and equipment, electronic apparatus and appliances, healthcare, oil and gas extraction, construction infrastructure and utilities, MRO, other manufacturing and assembly), and distribution channel (OEM, aftermarket) across seven key regions.

About Industrial Automation Division at Future Market Insights

The industrial automation team at Future Market Insights offers a novel approach and innovative perspective in analyzing the industrial automation market. Comprehensive coverage of capital, portable, process, construction, industrial and special purpose machinery across manufacturing sector and distinctive analysis about installed base, consumables, replacement, USP-feature-application matrix make us a pioneering voice in the industry. We are preferred associates with established as well as budding industry stakeholders and channel partners when it comes to sustain, grow and identify new revenue prospects.

Read Full Report @ https://www.futuremarketinsights.com/reports/polymer-seals-market

Global Polymer Seals Market by Category

By Material Type:

Polyurethane (PU)

Acrylonitrile-butadiene-rubber (NBR)

Fluoro-rubber (FKM)

Polytetrafluoroethylene (PTFE)

By Product Type:

Hydraulic and Pneumatic seals

Rotary Seals

Spring Energized Seals

By End Use:

Transportation Equipment

Automotive and Components

Aircraft and Components

Railroad Equipment

Marine Transportation and Components

Industrial Machinery and Equipment

Electronic Apparatus and Appliances

Healthcare

Medical Devices and Component Manufacturing

Surgical Tool manufacturing

Oil and Gas Extraction

Construction Infrastructure and Utilities

MRO, Other Manufacturing, and Assembly

By Distribution Channel:

OEM

Aftermarket

By Region:

North America

Latin America

Europe

East Asia

South Asia & Pacific

The Middle East and Africa

#Polymer Seals Market

0 notes

neovantage-park · 2 years

Text

Bio Pharma Laboratories in India| NEOVANTAGE-PARK

A Bio Pharma Laboratories in India is a facility where biological drugs are developed. Biopharmaceuticals are derived, manufactured, or semi-synthesized from living cells or organisms and are used to treat various diseases. Examples include certain vaccines, blood or blood components, stem cells, tissue and gene therapy. Finding the bio pharma laboratories in india is difficult but they can be easily found on the internet.These products can be difficult and expensive to produce, store, and ship, mainly because they are often heat-sensitive and easily contaminated. Biopharmaceuticals are often manufactured using sophisticated methods and therefore laboratories may require sophisticated equipment and technology.

#Laboratories in India #lab space in india #neovantage-park #lab space #lab

0 notes

marketresearch-articles · 3 years

Text

Cell Separation Technology Market Technologies Research Report Trend, Size, Share, Analysis, Growth, Opportunities-2028

Cell Separation Technology Market is grow at a CAGR 17.01% in the forecast 2021 to 2028.

Cell Separation Technology Market Scope and Size

· On the basis of technology type, the cell separation technology market is segmented into immunomagnetic cell separation, fluorescence-activated cell sorting, density gradient centrifugation, microfluidic cell separation and others.

· Based on application, the cell separation technology market is segmented into stem cell research, immunology, neuroscience, cancer research and others.

· On the basis of end user, the cell separation technology market is segmented into biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, academic and research institutes and others.

Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-separation-technology-market

Cell Separation Technology Market Country Level Analysis

Cell separation technology market is analyzed and market size insights and trends are provided by country, technology type, application and end user as referenced above.

The countries covered in the cell separation technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Cell Separation Technology Market Share Analysis

Cell separation technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cell separation technology market.

MAJOR TOC OF THE REPORT

Chapter One: Cell Separation Technology Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Cell Separation Technology Market Competition, by Players

Chapter Four: Global Cell Separation Technology Market Size by Regions

Chapter Five: North Cell Separation Technology Market by Countries

Chapter Six: Europe Cell Separation Technology Market Revenue by Countries

Chapter Seven: Asia-Pacific Cell Separation Technology Market Revenue by Countries

Chapter Eight: South America Cell Separation Technology Market Revenue by Countries

Chapter Nine: Middle East and Cell Separation Technology Market Revenue Equipment by Countries

Chapter Ten: Global Cell Separation Technology Market Segment by Type

Chapter Eleven: Global Cell Separation Technology Market Segment by Application

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-cell-separation-technology-market

The major players covered in the cell separation technology market report are Terumo Corporation, STEMCELL Technologies Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Miltenyi Biotec, Merck KGaA, Akadeum Life Sciences, Thermo Fisher Scientific Inc., BD, Bio-Rad Laboratories, Inc., Carl Zeiss AG, General Electric, QIAGEN, IBA Lifesciences GmbH, Elveflow, MPR Associates, Inc., PerkinElmer Inc., 10x Genomics, and ANGLE plc among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Access Full Report https://www.databridgemarketresearch.com/reports/global-cell-separation-technology-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports@

Radiology Services Market

Veterinary Lasers Market

0 notes

scientific-e-manufacturer · 3 years

Text

Plant Value Pack Manufacturer, Supplier and Exporter in India

All children are fascinated by gardens.

This kit allows them to see some of the ways plants are constructed as well as information about their habitats.

Charts:

1 x Flowers

1 x Roots

1 x Fruits

1 x Stems.

Models:

1 x Flower, 2D, raised relief

1 x Leaf, 2D, dicot, raised relief

1 x Root, dicot, raised relief, 37cm

1 x Stem, dicot, raised relief, 37cm.

Contact SEM for your School, College Science Physics Chemistry and Biology Lab Equipments. We are the best and renowned scientific laboratory equipments manufacturer, scientific laboratory equipments supplier, technical educational equipment exporter, technical educational equipment manufacturer, technical educational equipment supplier, technical educational equipments exporter in Ambala, India.

https://www.scientificequipmentsmanufacturer.com/value-kits/curriculum-kits/plant-value-pack

#PlantValuePackManufacturers #PlantValuePackExportersinIndia #PlantValuePackSuppliers #PlantValuePackManufacturersinIndia #PlantValuePackSuppliersinIndia

0 notes

researchdive · 3 years

Text

Cancer Stem Cells Market to Create Lucrative Opportunities for Existing Companies as Well as New Players

According to a study, Cancer Stem Cells Market by Research Dive, the global market will surpass $1,722.7 million by 2026. Rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the year 2026.

Rising tension of cancer all over the world is one of the significant factor which drives the growth of cancer stem cells market. According to the World Health Organization (WHO), one out of six deaths are occurs due to cancers such as breast cancer, lungs cancer and others. The causes for the growing cases of cancer patients include urban air pollution, sexually transmitted HPV infection, alcohol consumption, poor intake of fruit and vegetables. Moreover, late-stage presentation and inaccessible diagnosis are the common factor which increases risk of cancer. On the other hand, stem cell research has capability to manufacture different types of medicines for diseases along with finding drugs that can be used for treatment of cancer. However, issues such as expensive stem cell therapy treatments & strict international rules and are hampering the global cancer stem cells market growth. Such therapy utilizes living cells to treat disease coupled with processes like collecting, altering, storing and applying to technology. Thus, the cost of stem cell therapy ranges between $5,000 to $8,000 per stem cell treatment also it can be around $25,000 or more than that. Researchers of Tel Aviv University introduced newly advanced biosensor which can target leukemic stem cells. They are more focusing on decreasing the rate of relapse in blood cancer by targeting most malignant leukemic stem cells. Such latest technological advancements anticipated to drive the growth of market. Stem cell research is the rapidly growing medical practice in Turkey. Therefore, this country is now recognized as ‘rising star of Europe in stem cell’. Turkish hospitality and friendliness is well deserved along with ‘high quality, low cost stem cell treatment’, modern laboratory equipment creating enormous opportunities for the investors of stem cells.

Access to Exclusive PDF Sample Report Here! @ https://www.researchdive.com/download-sample/32

Segmentation Growth Definition of Cancer Stem Cells Market:

Breast cancer market will surpass $295.0 million in the year 2026, and is anticipated to rise at 10.4% CAGR during the estimate period. The cancer stem cells market for bladder is anticipated to increase at 11.2% CAGR, and will surpass $275.8 million by 2026, rising from $117.9 million in 2018.

Global market for stem cell based cancer therapy was $440.3 million by end of 2018 and is anticipated to grow at 9.3% CAGR. This is majorly due to the rising advancements in stem cell therapy of Asia-Pacific and Europe region.

Regional Investment Opportunities:

North America cancer stem cell market is generated revenue of $365.64 million by end of 2018 and is anticipated to rise at 10% CAGR during the analyzed period. Asia-Pacific market registered a growth rate of 11.2% during the forecast period. This market will surpass $367.68 million by 2026, growing from $157.26 million in 2018. China, India, and Japan are the key contributors to the growth of regional market.

Speak to our Expertise before buying Report@ https://www.researchdive.com/connect-to-analyst/32

Key players in cancer stem cells market and their strategies:

Some of the major players in the global cancer stem cells market are

AdnaGen GmbH

Advanced Cell Diagnostics, Inc.

AVIVA Biosciences Corporation

Celula, Inc.

Epic Sciences, Inc.

Fluxion Biosciences, Inc.

Rarecells USA, Inc.

Silicon Biosystems, S.p.A.

These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development etc. For instance, in January 2019, Fluxion Biosciences launched custom liquid biopsy NGS (Next Generation Sequencing) panel development. In liquid biopsy, NGS has been applied to sequencing of circulating tumor DNA. This technology has led to noteworthy reduction in the cost of sequencing coupled with improved accuracy.

#Cancer Stem Cells Market

0 notes

sandlerresearch · 3 years

Text

Laboratory Freezers Market by Product (Cryopreservation, Plasma Freezer, Explosion Proof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User (Hospitals) - Global Forecast to 2026 published on

https://www.sandlerresearch.org/laboratory-freezers-market-by-product-cryopreservation-plasma-freezer-explosion-proof-freezer-enzyme-freezer-ultra-low-freezer-blood-bank-refrigerator-pharmacy-refrigerator-chromatography-refr.html

“The global laboratory freezers market is projected to grow at a CAGR of 4.9%”

The laboratory freezers market is projected to reach USD 5.7 billion by 2026 from USD 4.7 billion in 2022, at a CAGR of 4.9%. Growth in the market is driven by the increasing demand for blood and blood components for transfusion and for support in cancer therapy.

The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 as they are extensively used for the proper storage of COVID-19 vaccines. The laboratory freezers market during 2022–2026 may show growth if booster doses of COVID-19 vaccines are made mandatory during the forecast period.

“The freezers segment holds the highest market share, by products, in the laboratory freezers market, in the forecast period.”

On the basis of products, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. In 2020, the freezers segment accounted for the largest share of 52.4% of the market. The large share of this segment can be attributed to their utility in pharmaceutical and biotechnology companies and academic and research institutes to support vaccine development and in medical laboratories and hospitals for storing test samples.

“The ultra-low-temperature freezers segment to grow at the highest CAGR in the freezers market, in the forecast period.”

The freezers market is segmented into enzyme freezers, plasma freezers, explosion-proof freezers, flammable material freezers, laboratory freezers, and ultra-low-temperature freezers. The ultra-low-temperature freezers segment is projected to grow at the highest CAGR during the forecast period. Growth in this segment is largely driven by the utility of these freezers to store sensitive stem cells, virus samples, bone grafts, and other biological samples used for research purposes.

“The laboratory refrigerators segment has the highest market share in the refrigerators market, in the forecast period.”

In this report, the refrigerators market is further segmented into blood bank refrigerators, chromatography refrigerators, explosion-proof refrigerators, flammable material refrigerators, laboratory refrigerators, and pharmacy refrigerators. The large share laboratory refrigerators segment is due to the utility of these products in the short-term storage of test samples in medical laboratories, hospitals, and clinics. These refrigerators meet routine laboratory storage requirements and simplify laboratory operations.

“North America holds the largest share in the laboratory freezers market, by region, in the forecast period”

The laboratory freezers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of the North American region is mainly due to the high healthcare expenditure in the US & Canada and the growing R&D spending on pharmaceuticals & biotechnology in this region. The presence of a large number of laboratory freezer and refrigerator manufacturers in the region also plays a pivotal role in boosting market growth, with the adoption of advanced laboratory freezers by different end-user segments.

A breakdown of the primary participants for the laboratory freezers market referred to for this report is provided below:

By Company Type: Tier 1–45%, Tier 2–35%, and Tier 3–20%

By Designation: C-level–46%, Director Level–37%, and Others–17%

By Region: North America–40%, Europe–30%, Asia Pacific–15%, Latin America – 10%, Middle East & Africa – 5%

The prominent players in the global laboratory freezers market are Eppendorf AG (Germany), Haier Biomedical (China), Thermo Fisher Scientific, Inc. (US), Helmer Scientific (US), PHC Holdings Corporation (Japan), Liebherr (Switzerland), Middleby Corporation (Follett Products, LLC), Felix Storch, Inc. (US), BioLife Solutions, Inc. (Stirling Ultracold) (US), Blue Star Limited (India), B Medical Systems (Luxembourg), Philipp Kirsch GmbH (Germany), Avantor, Inc. (US), Standex International Corporation (US), Vestfrost Solutions A/S (Denmark), Changhong Meiling Co. Ltd. (China), EVERmed S.R.L. (Italy), ARCTIKO A/S (Denmark), Glen Dimplex Medical Appliances (LEC Medical) (Ireland), So-Low Environmental Equipment Co. Ltd. (US), KW Apparecchi Scientifici SRL (Italy), Jeio Tech (Republic of Korea), Refrigerated Solutions Group (US), Stericox India Private Limited (India), Thalheimer Kühlung (Germany), and Antylia Scientific (US).

Research Coverage

The report analyzes the market for various laboratory freezers and their adoption pattern. It aims at estimating the market size and future growth potential of the laboratory freezers and different segments such as service offering, end user and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, products, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global laboratory freezers market.

Product Development/Innovation: Detailed insights on the upcoming trend, and product launches in the global laboratory freezers market.

Market Development: Comprehensive information on the lucrative emerging regions by products, end users, and region.

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global laboratory freezers market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global laboratory freezers market.

#Diagnostics

0 notes

healthcaremarketanalysis · 3 months

Text

Global Biobanking Market Worth $5.0 billion by 2028

The Global Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the growing investments and funding for biobanks, focus on genetic testing and precision medicine, increasing trend in the preservation of cord blood stem cells from newborns, and favorable funding scenario for research related to regenerative medicine. On the other hand, the high cost of automated equipment and issues related to biospecimen sample management are restraining the growth of this market.

Download PDF Brochure:

Biobanking Market Dynamics

DRIVER: Growing investments and funding for biobanks

RESTRAINT: High cost of automated equipment

OPPORTUNITY: Emerging countries to provide lucrative opportunities

CHALLENGE: High operational cost of biobanks

Request 10% Customization

The equipment segment dominated biobanking market by product & service:

Asia Pacific region of the global biobanking market, is estimated to register the highest CAGR during the forecast period.

The market in the Asia Pacific region has experienced significant growth over the past few years. This growth can be attributed to several factors, such as the increasing prevalence of chronic diseases, rising investments in research and development activities, and the expanding healthcare infrastructure. For instance, countries like China, Japan, and South Korea have witnessed a surge in biobanks and research initiatives aimed at understanding the genetic basis of diseases and developing personalized medicine. These countries have made substantial investments in biobanking infrastructure, including the establishment of state-of-the-art biorepositories and the implementation of stringent quality control measures.

Recent Developments

In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.

Report Link: ( Biobanking Market )

Biobanking market - Report Highlights:

The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall biobanking industry.

Recent developments help us to understand market trends and the growth strategies adopted by players in the market.

The new version of the report includes the ownership segment, which is further segmented into national/regional agencies, non-profit organizations, universities, and private organizations.

The new version of the report includes an end-user segment, which is further segmented into pharmaceutical & biotechnology companies and CROs, academic and research institutes, and hospitals.

#Biobanking Market #Biobanking Market Size #Biobanking Market Forecast #Biobanking Market Outlook

0 notes

decisionforsight · 3 years

Text

Global Biopreservation Market

Global Biopreservation Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

The global biopreservation market accounted 3.2 billion USD in 2020 and is expected to reach 13.2 billion USD by 2030 with a CAGR of 15.1% approximately during the forecast period.Biopreservation is a process that involves the preservation and storage of bio-specimens like purified DNA, saliva, and plasma. It enables the stability, quality, and purity of bio-specimens. The process of biopreservation is carried out with the help of lactic acid bacteria as they are inhibitory to microbes responsible for decomposition. It has developed as an effective preservation method for long-term storage. Because of this, biopreservation has become a vital tool for the success of numerous clinical and commercial applications of the developing cell-based technologies. Currently, it is been extensively used for retaining the integrity and functionality of clinical trials material, stem cells, embryos, sperms, and eggs in several research and healthcare institutions.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020172

Market Dynamics and Factors:

Growing prevalence of chronic disorders, rising healthcare expenditure, and increasing government spending on R&D are the major factors driving the global biopreservation market. For instance, according to the National Diabetes Statistics Report 2017, around 30 million people which comprises of almost 9.4% of the U.S. population had diabetes in 2015. Scarcity of organ donors for transplantation purposes is going to augment the demand for regenerative medicines which will in turn escalate the biopreservation market growth in the coming future. In addition to that, other major driving factors include growing research in drug discovery, increase in the number of bio-banks to store biological products used in various kinds of medical research, and government initiatives to promote bio-banking for disease treatment. For instance, government initiatives such as International Society of Biological and Environmental Repositories to enrich bio-banking and preservation standards and practices is creating huge opportunities for the biopreservation market to grow in the coming future. However, certain factors like high cost of biopreservation devices, stringent norms for the production of biopreservation products, and the emergence of room temperature storage techniques are hindering the growth of the biopreservation market. Furthermore, increasing R&D by key players in order to enhance their capabilities and provide efficient products and services is expected to further expand growth prospects for the market.

Market Segmentation:

Global Biopreservation Market – By Product Type

Equipments

Freezers

Refrigerators

Consumables

Liquid Nitrogen

Media

Nutrient Media

Sera

Growth Factors & Supplements

Laboratory Information Management System

Global Biopreservation Market – By Application

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Biobanking

Human Eggs

Human Sperms

Veterinary Ivf

Drug Discovery

Global Biopreservation Market – By Cell Providers Volume

Cd 34+

Cd19+

MSC

IPSC

HESC

Tumor Cells

Others

Global Biopreservation Market – By End-Users

Hospitals

Bio-Banks

Gene Banks

Others

Global Biopreservation Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020172

Geographic Analysis:

North America is expected to dominate the global biopreservation market in terms of market share during the forecast period. Increasing prevalence of chronic disorders like diabetes, renal failure leading to organ damage has augmented the scope of organ transplantation in the region. Thus, positively impacting the biopreservation market in the region. For instance, according to the U.S. Department of Health & Human Services, almost 114,000 people were on the national transplant waiting list as of August 2017. This in turn has increased the adoption rate of regenerative medicine in disease treatment and contributed to the growth of the biopreservation market in the region. Other major factors include robust healthcare infrastructure, and government investments in R&D attributing to the market dominance of the region. Europe is expected to be the second most dominating market for biopreservation products during the forecast period. Increasing government support in networking of bio-banks such as UK Bio-bank and international collaborations for expanding the scope of bio-banking are the major factors attributing to the market growth in the region. The Asia Pacific market is anticipated to witness the fastest growth in the biopreservation market during the forecast period. Consistent rise in number of patients suffering from chronic diseases, and increasing government investments in R&D is widening the scope for adoption of bio-storage, thereby boosting the market growth across the APAC region.

Competitive Scenario:

The key players operating in the global biopreservation market are –

BioLife Solutions, BioCision, Biomatrica, Chart MVE Biomedical, Thermo Fisher Scientific, Panasonic Biomedical, Taylor-Wharton Cryogenics, Atlanta Biologics, Qiagen, Princeton Cryotech Inc.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020172

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Biopreservation industry, although key threats, opportunities and disruptive technologies that could shape the Global Biopreservation Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Biopreservation Market most.

The data analysis present in the Global Biopreservation Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Biopreservation Market business.

The 2021 Annual Global Biopreservation Market offers:

100+ charts exploring and analysing the Global Biopreservation Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biopreservation Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020172

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: [email protected]

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

0 notes

neovantage-park · 2 years

Text

Biopharma Labs For Lease| NEOVANTAGE-PARK

Biopharma companies that want Biopharma lab space for lease in India can carry out production in the right infrastructure that follows Good Manufacturing Practices.. Biopharmaceuticals are derived, manufactured, or semi-synthesized from living cells or organisms and are used to treat various diseases. Examples include certain vaccines, blood or blood components, stem cells, tissue, and gene therapy. Finding biopharma laboratories in India is difficult but they can be easily found on the internet. These products can be difficult and expensive to produce, store, and ship, mainly because they are often heat-sensitive and easily contaminated. Biopharmaceuticals are often manufactured using sophisticated methods and therefore laboratories may require sophisticated equipment and technology.

#NEOVANTAGE-PARK #neovantage-park #lab space in india #lab space #lab

0 notes

marketresearch-articles · 3 years

Text

Cell Separation Technology Market Share by 2028: Upcoming Trends and Analysis

Cell Separation Technology Market is grow at a CAGR gain in the forecast 2021 to 2028.

Cell Separation Technology Market Scope and Size

· Based on application, the cell separation technology market is segmented into stem cell research, immunology, neuroscience, cancer research and others.

Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-separation-technology-market

Cell Separation Technology Market Country Level Analysis

Cell separation technology market is analyzed and market size insights and trends are provided by country, technology type, application and end user as referenced above.

Competitive Landscape and Cell Separation Technology Market Share Analysis

MAJOR TOC OF THE REPORT

Chapter One: Cell Separation Technology Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Cell Separation Technology Market Competition, by Players

Chapter Four: Global Cell Separation Technology Market Size by Regions

Chapter Five: North Cell Separation Technology Market by Countries

Chapter Six: Europe Cell Separation Technology Market Revenue by Countries

Chapter Seven: Asia-Pacific Cell Separation Technology Market Revenue by Countries

Chapter Eight: South America Cell Separation Technology Market Revenue by Countries

Chapter Nine: Middle East and Africa Cell Separation Technology Market Revenue Equipment by Countries

Chapter Ten: Global Cell Separation Technology Market Segment by Type

Chapter Eleven: Global Cell Separation Technology Market Segment by Application

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-cell-separation-technology-market

major players covered in the cell separation technology market report are Terumo Corporation, STEMCELL Technologies Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Miltenyi Biotec, Merck KGaA, Akadeum Life Sciences, Thermo Fisher Scientific Inc., BD, Bio-Rad Laboratories, Inc., Carl Zeiss AG, General Electric, QIAGEN, IBA Lifesciences GmbH, Elveflow, MPR Associates, Inc., PerkinElmer Inc., 10x Genomics, and ANGLE plc among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Access Full Report https://www.databridgemarketresearch.com/reports/global-cell-separation-technology-market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports@

Revenue Cycle Management (RCM) Market

Stem Cell manufacturing Market

0 notes

rishabh3210blog · 3 years

Text

Global Fetal Bovine Serum Market Size, Growth Analysis Report, Forecast to 2021-2027

The global fetal bovine serum market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The factors contributing to the growth of the market include the rising consumption of fetal bovine serum in various applications and industries such as pharmaceutical & biotechnology and increasing academic research globally. Besides, to generate more revenue and expanding the market the key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/fetal-bovine-serum-market

For instance, in March 2021, Thermo Fisher Scientific Inc, has launched the new Gibco Human Plasma-like Medium (HPLM) which provides a realistic view of cell growth within the human body. It is the first-ever cell culture medium that tends to mimic the metabolic profile of the human plasma. The HPLM provides researchers with the ability to study the impact of physiologically relevant cell media on their specific research applications which include cancer and other diseases. In the supplementation with fetal bovine serum, cell growth and viability can be achieved by HPLM. The new launch adds Thermo Fisher Scientific Inc to remain competitive in the fetal bovine serum market by expanding its product offering.

A Full Report of Global Fetal Bovine Serum Market is Available at: https://www.omrglobal.com/industry-reports/fetal-bovine-serum-market

Moreover, in December 2019, Sartorius AG acquired 50% shares of the Israeli cell culture media manufacturer and developer Biological Industries Ltd. for approximately $54 million in cash. Biological has specialization in cell culture media ad gene therapy. With this acquisition, Sartorius had expanded its business in the cell cultural media segment by offering a broad range of products that drives the market growth. Additionally, the acquisition helped Sartorius to remain competitive in the dynamically growing company in the field of life science and biotechnology. Considering these activities, significant growth can be expected in the market during the forecast period.

Global Fetal Bovine Serum Market Report Segment

By Product Type

Charcoal Stripped

Chromatographic

Dialyzed FBS

Stem Cell

Others (Exosome Depleted)

By End-User

Bioproduct & Pharmaceutical Company

Research Laboratory

Academic Institute

Others (Cell Bank)

By Application

Industrial Research

Scientific Research

Global Fetal Bovine Serum Market Report Segment by Region

North America

United States

Canada

Europe

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of the Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fetal-bovine-serum-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404

0 notes

adwaitcoherent · 4 years

Text

From US$ 24,961.0 Mn in 2020, to US$ 44,373.4 Mn in 2027, Cell Surface Markers Market shows prominent growth.

While major players in the market are focused on product approval and launch Cell Surface Markers Market To Reach CAGR of 8.6% till 2027.

Request for Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/3912

Description:

The study of cell surface markers is crucial in the evaluation of cell proliferation, abnormal cell populations and quantification and assessment of minimal residual diseases. Growing focus on disease prevention and reduction of overall healthcare expenditure has resulted in an increase in acceptance and adoption of analytical technologies such as cell surface marker analysis and in vitro diagnostics tools. The global cell surface markers market is estimated to account for US$ 24,961.0 Mn in terms of value in 2020 and is expected to reach US$ 44,373.4 Mn by the end of 2027.

Global Cell Surface Markers Market: Drivers Increasing prevalence of cancer is expected to propel growth of the global cell surface markers market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Figure 1. Global Cell Surface Markers Market Share (%), by Value, by Region, 2019

Global Cell Surface Markers Market: Opportunities Advances in surface markers are expected to offer lucrative growth opportunities for players in the global cell surface markers market. For instance, therapies targeting liver cancer stem cells can improve the efficacy of conventional chemotherapy and radiotherapy in the treatment of liver cancer. In this regard, a research by The Ohio State University, U.S., in May 2018, reported that INK128, an ATP-competitive mTOR inhibitor, can suppress CD44+ -- a liver cancer stem cell surface marker— and sorafenib insensitive hepatocellular carcinoma in vitro and in vivo.

Global Cell Surface Markers Market: Restraints Complexity in the use of flow cytometers is expected to hinder growth of the market. Lack of expertise in the use of such equipment, especially in markets with low awareness such as some parts of Asia Pacific and Middle East has resulted in less use and purchase of high-end flow cytometers in these regions. In recent years, the complexity of flow cytometry methodologies has significantly increased, particularly in relation to the quantity of simultaneous measurements available in such devices. Furthermore, the areas of spectral overlap, accuracy of collected data, issues of complex data processing and cluster identification automation can create several problems in the use of flow cytometry both in research and disease diagnosis.

Figure 2. Global Cell Surface Markers Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Key Takeaways: The global cell surface markers market was valued at US$ 23,037.4 Mn in 2019 and is forecast to reach a value of US$ 44,373.4 Mn by 2027 at a CAGR of 8.6% between 2020 and 2027. Major factor driving the growth of global cell surface markers market during the forecast period include growing automation in laboratories, and increasing adoption of in vitro diagnostics

North America held dominant position in the global cell surface markers market in 2019, accounting for 37.5% share in terms of value, followed by Europe and Asia Pacific, respectively. Presence of leading manufacturers in the region, and wide customer base is supporting growth of the market.

Market Trends Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in April 2019, Beckman Coulter received 510(k) clearance from the U.S. Food and Drug Administration for its Early Sepsis Indicator, a hematology-based cellular biomarker that is designed to help emergency department physicians identify patients with sepsis or at increased risk of developing sepsis. Major players in the market are focused on adopting various marketing strategies to enhance their market share. For instance, in June 2019, Bio-Rad Laboratories, Inc. participated in Jefferies 2019 Global Healthcare Conference, held in New York, U.S.

Cell Surface Markers Market Report Coverage

Global Cell Surface Markers Market: Competitive Landscape

Major players operating in the global cell surface markers market include, Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Global Cell Surface Markers Market: Key Developments September 2019: F. Hoffmann-La Roche Ltd presented OCREVUS (ocrelizumab) biomarker data that highlights new insights into the biology of multiple sclerosis at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in Stockholm, Sweden.

Buy this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/3912

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.

Mr. Shah

Coherent Market Insights

1001 4th Ave.

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

#CELL SURFACE MARKERS MARKET ANALYSIS #Coherent Market Insights #Market Research #Business Consulting #Market Analysis

0 notes